Pluto Biosciences, Inc. — Form D
Pluto Biosciences, Inc. of Denver, CO, a company, filed a Form D exempt-offering notice with the SEC on 2023-05-15. The offering totals $3.7M, of which $3.7M was reported sold. Industry: Other Technology.
Offering
- Filed: 2023-05-15
- Form: D
- Accession: 0001877480-23-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $3.7M
- Amount sold: $3.7M
- Investors: 14
- Date of first sale: 2023-05-01
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-481742
Issuer
- Name: Pluto Biosciences, Inc.
- CIK: 0001877480
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 3575 Ringsby Court, Denver, CO, 80216
- Phone: 719-247-0726
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Dalton K Wright | Director | Denver, CO |
| Rani K Powers | Director | Denver, CO |
| Rani K Powers | Executive Officer | Denver, CO |
| Christopher K Glode | Director | Denver, CO |
| Mike K Dodd | Director | Denver, CO |
Other filings by this issuer (2)
More